Medtronic Plc

XNYS:MDT 4:00:00 PM EDT

90.97

-0.76 (-0.83%)

7:59:15 PM EDT: $90.60 -0.37 (-0.41%)

Market Cap (Intraday)	116.68B
Current PE	25.04
Forward PE	16.16
2yr Forward PE	14.96

See more stats

Estimates Current Quarter

Revenue	$8.87 Billion
Adjusted EPS	$1.31

See more estimates

10-Day MA	$93.58
50-Day MA	$94.01
200-Day MA	$88.63

See more pivots

Medtronic Plc Stock, XNYS:MDT

Parkmore Business Park West, Building Two, Galway, Galway 2

Ireland

Phone: +353.1.438.1700

Number of Employees: 95000

http://www.medtronic.com

Description

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.